GEN Magazine

Volume 43, Issue No. 10, October 2023

October 2023 Issue of GEN

Progress against cardiovascular disease appears to have stalled, particularly with respect to measures such as premature heart disease mortality. Indeed, in recent years, such measures tell a story of momentum gained, then lost. So, in addition to doubling down on existing treatments, we need new ones. As this issue of GEN reports, new treatments—gene therapies, antibody fragments, and microRNA drug products—promise to restore medicine’s momentum against cardiovascular disease. In addition, this issue of GEN makes the case that in other fields—namely, next-generation sequencing, AAV vector design and manufacturing, and AI-driven bioprocessing—momentum-building projects continue apace. Finally, this issue of GEN presents our latest A-List: Top 10 Contract Development and Manufacturing Organizations. Besides ranking the leading CDMOs by revenue, we highlight recent announcements that show how CDMOs are exploring new product categories, building end-to-end service offerings, and cultivating more lasting relationships with clients.

Website Content from This Issue

New Drugs May Help Rebuild Momentum against Cardiovascular Disease

Formation of a blood clot

Strengthening the Flow of the Biotech Sector’s M&A Pipeline

Handshake Birds Eye View

Why Recombinants Are Essential for Assay Development and Production

Scripps Assay Development

Set to Join the NGS Race, Ultima Genomics Offers a Peek under the Hood

DNA test infographic. Genome sequence

Manage Data Better or Die

Terumo Blood and Cell Technologies cell processing

Making AAVs the Go-To for Making Gene Therapies Go

Asklepios BioPharmaceutical (AskBio) researcher

Human Commensal Viruses as Gene Therapy Vectors


Biopharma Taps Bioprocessing 4.0, Benefits Start Flowing

Female engineer with digital tablet examining development of industrial product

Synthetic DNA and RNA Can Open New Manufacturing Workflows

Aldevron production

The Time Is Right for Single-Cell Genomics: Next-Generation Sequencing Has Enabled the Single-Cell Multiomics Revolution

BioSkryb Data Flowers illustration

De-risking Cell Therapy New Product Introduction

Harnessing the Power of the Proteome

Quantum-Si’s first-of-its-kind Platinum™ next- generation protein sequencing instrument

Mimicking the In Vivo Environment for Cardiovascular Studies

Blocked Blood Vessel

Rentschler Biopharma: Committed to Advancing Cell and Gene Therapies

Rentschler Biopharma researchers

The Foundation for Tomorrow’s Medicines: Complete Accessible Sequencing Solutions

Complete Genomics website hero image

The Many Benefits of Implementing FAIR Assay Annotation

Researchers With Computer

Microscoop Revolutionizes Hypothesis-Free Proteomics





Rx Corner

Human T Cell Activation and Expansion Kit

Dual Entry Fume Hoods


Multiomic Profiling Kit

Can CRISPR Crack the Code to Treating HIV Infections?

Top 10 Contract Development and Manufacturing Organizations

Lonza lab

Genotoxic Effects by Base and Prime Editors in Human HSPCs Aren’t Surprising, Says Pioneer

DNA Molecule Helix Genetic Code - stock photo

Cancer Cells Turn into Muscle Cells, Potentially Enabling Differentiation Therapy

Sarcoma cells

Naked Mole Rat Longevity Gene Lengthens Lifespan of Mice

mole rat